Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System

Lindroos, 1993, Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample, J Am Coll Cardiol, 2, 1220, 10.1016/0735-1097(93)90249-Z

Iung, 2003, A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease, Eur Heart J, 24, 1231, 10.1016/S0195-668X(03)00201-X

Ross, 1968, Aortic stenosis, Circulation, 38 Suppl, 61

Rosenhek, 2010, Natural history of very severe aortic stenosis, Circulation, 121, 151, 10.1161/CIRCULATIONAHA.109.894170

Clark, 2012, Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis, Circ Cardiovasc Qual Outcomes, 5, 697, 10.1161/CIRCOUTCOMES.112.966002

Nishimura, 2014, 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, e57, 10.1016/j.jacc.2014.02.536

Vahanian, 2012, Guidelines on the management of valvular heart disease (version 2012), Eur Heart J, 33, 2451, 10.1093/eurheartj/ehs109

Iung, 2005, Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?, Eur Heart J, 26, 2714, 10.1093/eurheartj/ehi471

Bach, 2009, Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk, Circ Cardiovasc Qual Outcomes, 2, 533, 10.1161/CIRCOUTCOMES.109.848259

Smith, 2011, Transcatheter versus surgical aortic valve replacement in high-risk patients, N Engl J Med, 364, 2187, 10.1056/NEJMoa1103510

Adams, 2014, Transcatheter aortic-valve replacement with a self-expanding prosthesis, N Engl J Med, 370, 1790, 10.1056/NEJMoa1400590

Tchetche, 2010, Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprosthesis in a mixed population, EuroIntervention, 5, 659, 10.4244/EIJV5I6A109

Van Mieghem, 2010, Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience, EuroIntervention, 5, 673, 10.4244/EIJV5I6A111

Fraccaro, 2011, Incidence, predictors, and outcome of conduction disorders after transcatheter self-expanding aortic valve implantation, Am J Cardiol, 107, 747, 10.1016/j.amjcard.2010.10.054

van der Boon, 2012, New conduction abnormalities after TAVI—frequencies and causes, Nat Rev Cardiol, 9, 454, 10.1038/nrcardio.2012.58

Kodali, 2011, Two-year outcomes after transcatheter or surgical aortic-valve replacement, N Engl J Med, 366, 1686, 10.1056/NEJMoa1200384

Sherif, 2010, Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis, J Am Coll Cardiol, 56, 1623, 10.1016/j.jacc.2010.06.035

Eggebrecht, 2012, Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients, EuroIntervention, 8, 129, 10.4244/EIJV8I1A20

Nuis, 2012, Frequency and causes of stroke during or after transcatheter aortic valve implantation, Am J Cardiol, 109, 1637, 10.1016/j.amjcard.2012.01.389

Lange, 2011, Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients, Eur J Cardiothorac Surg, 40, 1105

Ribeiro, 2013, Coronary obstruction following transcatheter aortic valve implantation: a systematic review, J Am Coll Cardiol Intv, 6, 452, 10.1016/j.jcin.2012.11.014

Sinning, 2013, Medtronic CoreValve Evolut R with Enveo R, EuroIntervention, 9, s95, 10.4244/EIJV9SSA18

Kappetein, 2012, Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document, J Am Coll Cardiol, 60, 1438, 10.1016/j.jacc.2012.09.001

Leon, 2010, Transcatheter aortic valve implantation for aortic stenosis in patients who cannot undergo surgery, N Engl J Med, 363, 1597, 10.1056/NEJMoa1008232

Popma, 2014, Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery, J Am Coll Cardiol, 63, 1972, 10.1016/j.jacc.2014.02.556

Meredith, 2014, Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study, J Am Coll Cardiol, 64, 1339, 10.1016/j.jacc.2014.05.067

Manoharan G. Multicentre clinical study evaluating a novel resheathable self-expanding transcatheter aortic valve system. Paper presented at: Transcatheter Therapeutics; September 13, 2014; Washington, DC.

Schofer, 2014, Prospective multicenter evaluation of the Direct Flow Medical transcatheter aortic valve, J Am Coll Cardiol, 63, 763, 10.1016/j.jacc.2013.10.013

Webb, 2014, Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve, J Am Coll Cardiol, 64, 2235, 10.1016/j.jacc.2014.09.026

Ribeiro, 2013, Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry, J Am Coll Cardiol, 62, 1552, 10.1016/j.jacc.2013.07.040

Holmes, 2012, 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement, J Am Coll Cardiol, 59, 1200, 10.1016/j.jacc.2012.01.001

Pasic, 2012, Rupture of the device landing zone during transcatheter aortic valve implantation: a life-threatening but treatable complication, Circ Cardiovasc Interv, 5, 424, 10.1161/CIRCINTERVENTIONS.111.967315

Tchetche, 2012, Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system, EuroIntervention, 8, 556, 10.4244/EIJV8I5A86

Tzikas, 2011, Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction, Am J Cardiol, 107, 285, 10.1016/j.amjcard.2010.09.015

Webb, 2012, Current status of transcatheter aortic valve replacement, J Am Coll Cardiol, 60, 483, 10.1016/j.jacc.2012.01.071

Petronio AS, Zucchelli G, Kovac J, de Jaegere P. ADVANCE II: best practices investigation in patients undergoing transcatheter aortic valve implantation with a self-expanding valve. Paper presented at: Annual Meeting of the EuroPCR; May 22, 2014; Paris, France.

Piazza, 2010, Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation, EuroIntervention, 6, 475, 10.4244/EIJ30V6I4A80

Sinning, 2012, Aortic regurgitation index predicts severity or peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation, J Am Coll Cardiol, 59, 1134, 10.1016/j.jacc.2011.11.048

Takagi, 2011, Predictors of moderate-to-severe paravalvular regurgitation immediately after CoreValve implantation and the impact of postdilation, Catheter Cardiovasc Interv, 78, 432, 10.1002/ccd.23003

Pibarot, 2014, Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER Trial Cohort-A analysis, J Am Coll Cardiol, 64, 1323, 10.1016/j.jacc.2014.06.1195